ECHOGO
LIVE

Serial Number

88291660

Owner

Ultromics Limited

Attorney

Andrea L Calvaruso

Filing Date

Feb 6, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ECHOGO Trademark

Serial Number: 88291660 • Registration: 6172336

ECHOGO is a trademark filed by Ultromics Limited on February 6, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Ultromics Limited (3 trademarks)

4630 Kingsgate, Cascade Way
Oxford OX42SU , GB

Entity Type: 99

Trademark Details

Filing Date

February 6, 2019

Registration Date

October 13, 2020

Published for Opposition

July 28, 2020

Goods & Services

downloadable software for operating and managing databases in the field of cardiology; recorded software for operating and managing databases in the field of cardiology; downloadable software for operating and managing data banks in the field of cardiology; recorded software for operating and managing data banks in the field of cardiology; downloadable software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; recorded software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; application software for handheld computers, namely, downloadable software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; application software for handheld computers, namely, recorded software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; downloadable computer software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; recorded computer software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; downloadable software applications for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; recorded software applications for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; software relating to data analytics being downloadable software for analyzing patient data from medical patient monitoring and diagnostic equipment; software relating to data analytics being recorded software for analyzing patient data from medical patient monitoring and diagnostic equipment; downloadable artificial intelligence software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; recorded artificial intelligence software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; downloadable software for use in medical diagnosis, namely, for interpreting the results of echocardiograms; recorded software for use in medical diagnosis, namely, for interpreting the results of echocardiograms; echocardiography software being downloadable software for interpreting the results of echocardiograms; echocardiography software being recorded software for interpreting the results of echocardiograms; all of the aforesaid goods relating to or connected with the identification, imaging, diagnosis and treatment of cardiovascular conditions and coronary heart disease

Medical services; medical diagnostic services; medical imaging services; providing medical information to medical professionals in the form of medical reports in the field of cardiology; medical screening relating to the heart; medical services, namely, medical testing, screening and analysis for diagnostic and treatment purposes; medical services, namely, medical testing, screening and analysis services relating to the diagnosis and treatment of disease; medical services, namely, medical testing, screening and analysis services relating to the diagnosis and treatment of cardiovascular disease; all of the aforesaid services relating to or connected with the identification, imaging, diagnosis and treatment of cardiovascular conditions and coronary heart disease

Research and development services in the field of cardiology; medical research and development services in the field of cardiology; scientific research and development services; pharmaceutical research and development services; design services, namely, medical diagnostic apparatus and instrument design services; research, design and development of medical apparatus and instruments; research, design and development of medical diagnostic apparatus and instruments; research, design and development of cardiovascular diagnostic testing apparatus and instruments; product design, research and development services in the field of artificial intelligence related to the field of medicine, medical diagnosis and cardiology; design, research, development, maintenance, updating, testing, customisation, implementation, installation and rental of software, computer software, software programs, application software and software applications in the field of cardiology; technical support being software programming, installation, and advisory and information services in the field of software programming and installation in the field of medicine, medical diagnosis and cardiology; maintenance and repair services for software, computer software, application software and software applications in the field of medicine, medical diagnosis and cardiology; software as a service (SAAS) services featuring software for use in the field of medicine and medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical diagnosis purposes; cloud computing services, namely, cloud hosting provider services in the field of medicine, medical diagnosis and cardiology; all of the aforesaid services relating to or connected with the identification, imaging, diagnosis and treatment of cardiovascular conditions and coronary heart disease

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 13, 2025 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 24, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 24, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 24, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 24, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 24, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Oct 13, 2020 R.PR
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Aug 4, 2020 ISPO
TEAS DELETE 1(B) BASIS RECEIVED
Aug 3, 2020 D1BR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 28, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 28, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 8, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 18, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 18, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 18, 2020 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 22, 2020 GNFN
FINAL REFUSAL E-MAILED
Apr 22, 2020 GNFR
FINAL REFUSAL WRITTEN
Apr 22, 2020 CNFR
DATA MODIFICATION COMPLETED
Apr 21, 2020 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 31, 2020 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 25, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 25, 2019 GNSL
SUSPENSION LETTER WRITTEN
Nov 25, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2019 CRFA
ASSIGNED TO LIE
Oct 30, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 23, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 23, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 23, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 18, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2019 NWOS
NEW APPLICATION ENTERED
Feb 9, 2019 NWAP